Autolus Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
463
- Stock Symbol
-
AUTL
- Share Price
-
$2.33
- (As of Wednesday Closing)
Autolus General Information
Description
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Contact Information
Website
www.autolus.comCorporate Office
- The Mediaworks, 191 Wood Lane
- White City
- London W12 7FP
- England, United Kingdom
Corporate Office
- The Mediaworks, 191 Wood Lane
- White City
- London W12 7FP
- England, United Kingdom
Autolus Timeline
Autolus Stock Performance
As of 15-Jan-2025, Autolus’s stock price is $2.33. Its current market cap is $620M with 266M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.33 | $2.21 | $2.07 - $7.37 | $620M | 266M | 1.91M | -$1.22 |
Autolus Financials Summary
As of 30-Sep-2024, Autolus has a trailing 12-month revenue of $10.1M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 310,005 | 916,533 | 180,885 | 227,200 |
| Revenue | 10,091 | 1,698 | 6,194 | 1,507 |
| EBITDA | (220,432) | (170,240) | (133,948) | (132,505) |
| Net Income | (270,227) | (208,383) | (148,839) | (142,096) |
| Total Assets | 827,490 | 375,381 | 490,274 | 405,560 |
| Total Debt | 52,229 | 52,967 | 24,256 | 20,998 |
Autolus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Autolus Comparisons
Industry
Financing
Details
Autolus Competitors (36)
One of Autolus’s 36 competitors is Transgene, a Corporation company based in Illkirch-Graffenstaden, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Transgene | Corporation | Illkirch-Graffenstaden, France | ||||
| Gilead Sciences | Formerly VC-backed | Foster City, CA | ||||
| VBI Vaccines | Private Debt Financed | Cambridge, MA | ||||
| XBiotech | Corporation | Austin, TX | ||||
| Immatics | Formerly VC-backed | Tuebingen, Germany |
Autolus Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Autolus Patents
Autolus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202414148-D0 | Products and method for treating autoimmune diseases | Pending | 26-Sep-2024 | ||
| GB-202412689-D0 | Products and methods for treating autoimmine disease | Pending | 29-Aug-2024 | ||
| GB-202408341-D0 | Method | Pending | 11-Jun-2024 | ||
| GB-202404412-D0 | Products and methods for treating autoimmune diseases | Pending | 27-Mar-2024 | ||
| GB-202403564-D0 | Method | Pending | 12-Mar-2024 |
Autolus Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Autolus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Autolus ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Autolus FAQs
-
When was Autolus founded?
Autolus was founded in 2014.
-
Where is Autolus headquartered?
Autolus is headquartered in London, United Kingdom.
-
What is the size of Autolus?
Autolus has 463 total employees.
-
What industry is Autolus in?
Autolus’s primary industry is Biotechnology.
-
Is Autolus a private or public company?
Autolus is a Public company.
-
What is Autolus’s stock symbol?
The ticker symbol for Autolus is AUTL.
-
What is the current stock price of Autolus?
As of 15-Jan-2025 the stock price of Autolus is $2.33.
-
What is the current market cap of Autolus?
The current market capitalization of Autolus is $620M.
-
What is Autolus’s current revenue?
The trailing twelve month revenue for Autolus is $10.1M.
-
Who are Autolus’s competitors?
Transgene, Gilead Sciences, VBI Vaccines, XBiotech, and Immatics are some of the 36 competitors of Autolus.
-
What is Autolus’s annual earnings per share (EPS)?
Autolus’s EPS for 12 months was -$1.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
